Lameijer, M., Binderup, T., van Leent, M., Senders, M., Fay, F., Malkus, J., Sanchez-Gaytan, B., Teunissen, A., Karakatsanis, N., Robson, P., Zhou, X., Ye, Y., Wojtkiewicz, G., Tang, J., Seijkens, T., Kroon, J., Stroes, E., Kjaer, A., Ochando, J., Reiner, T., Pérez-Medina, C., Calcagno, C., Fisher, E., Zhang, B., Temel, R., Swirski, F., Nahrendorf, M., Fayad, Z., Lutgens, E., Mulder, W., & Duivenvoorden, R. (2018). efficacy and safety assessment of a TRAF6-targeted nanoimmunotherapy in atherosclerotic mice and non-human primates. Nature biomedical engineering, 2, 279–292. http://access.bl.uk/ark:/81055/vdc_100079355731.0x000114